GPC3 and hepatocellular carcinoma: Glypican-3 (GPC3), a cell surface heparan sulfate proteoglycan, is an attractive therapeutic target and useful diagnostic biomarker because it is expressed at high levels in the plasma membrane of HCC cells, but not expressed in normal adult liver tissue [25,26].